Literature DB >> 23439758

Paradoxical immune reconstitution inflammatory syndrome associated with rituximab-containing regimen in a patient with lymphoma.

Jonathan Canaani1, Sharon Amit, Jonathan Ben-Ezra, Mehrzad Cohen Pour, Nadav Sarid, Hedva Lerman, Chava Perry, Aaron Polliack, Elizabeth Naparstek, Yair Herishanu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23439758     DOI： 10.1200/JCO.2012.43.6188

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  [Immune reconstitution inflammatory syndrome after cessation of immunosuppressive therapy].

Authors:  B Ehrenstein
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

2.  Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia.

Authors:  Waleed Elsegeiny; Taylor Eddens; Kong Chen; Jay K Kolls
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

Review 3.  Immune reconstitution inflammatory syndrome associated with biologic therapy.

Authors:  Malika Gupta; Kashif Jafri; Rebecca Sharim; Susanna Silverman; Sayantani B Sindher; Anupama Shahane; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.919
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.